State of New Jersey Common Pension Fund D’s BioCryst Pharmaceuticals BCRX Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio BCRX Stock Details BCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$669K	Sell	66,903 -3,927	-6%	-$35.5K	﹤0.01%	1598
2026 Q1	$674K	Buy	+70,830	New	+$550K	﹤0.01%	1430
2023 Q3	–	Sell	-289,701	Closed	-$2.04M	–	1621
2023 Q2	$2.04M	Buy	289,701 +52,086	+22%	+$418K	0.01%	1552
2023 Q1	$1.98M	Buy	237,615 +49,616	+26%	+$478K	0.01%	1489
2022 Q4	$2.16M	Buy	187,999 +22,658	+14%	+$283K	0.01%	1386
2022 Q3	$2.08M	Sell	165,341 -84,298	-34%	-$1.08M	0.01%	1270
2022 Q2	$2.64M	Buy	249,639 +107,262	+75%	+$1.11M	0.01%	947
2022 Q1	$2.31M	Sell	142,377 -93,840	-40%	-$1.51M	0.01%	1531
2021 Q4	$3.27M	Buy	236,217 +51,327	+28%	+$679K	0.01%	974
2021 Q3	$2.66M	Buy	184,890 +11,989	+7%	+$189K	0.01%	1353
2021 Q2	$2.73M	Buy	172,901 +72,901	+73%	+$990K	0.01%	1187
2021 Q1	$1.02M	Buy	+100,000	New	+$1.03M	﹤0.01%	1657

Other funds holding BCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

IMC Chicago Chicago, Illinois $419B AUM 72.04% 1-Year Est. Return

OAM

OP Asset Management Helsinki $9.38B AUM 42.35% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

State of New Jersey Common Pension Fund D's BCRX Position: Q2 2026 in Review

State of New Jersey Common Pension Fund D reduced its BioCryst Pharmaceuticals (BCRX) stake by 5.5% in Q2 2026, selling an estimated $35.5K and leaving 66,903 shares worth $669K. The position accounts for ﹤0.01% of the portfolio, ranked #1598.

State of New Jersey Common Pension Fund D first reported a position in BCRX in Q1 2021 and has held it in 12 quarters since. The position peaked at $3.27M in Q4 2021. 115 funds tracked by Wall St. Rank hold BCRX as of Q2 2026.

State of New Jersey Common Pension Fund D held 66,903 shares of BioCryst Pharmaceuticals worth $669K as of Q2 2026.
State of New Jersey Common Pension Fund D sold 3,927 BioCryst Pharmaceuticals shares in Q2 2026, an estimated $35.5K.
BioCryst Pharmaceuticals made up ﹤0.01% of State of New Jersey Common Pension Fund D's portfolio in Q2 2026, its #1598 holding.
State of New Jersey Common Pension Fund D first reported a position in BioCryst Pharmaceuticals in Q1 2021 and has held it in 12 quarters since.
State of New Jersey Common Pension Fund D's BioCryst Pharmaceuticals position peaked at $3.27M in Q4 2021.
115 funds tracked by Wall St. Rank held BioCryst Pharmaceuticals as of Q2 2026.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q2 2026, filed 4 Aug 2026.